Thermo Fisher Scientific Inc. (TMO) — Stock Price, Chart & Analysis
Thermo Fisher Scientific Inc. (TMO) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $243.49B and a trailing P/E ratio of 35.44. Over the past 52 weeks, TMO has traded between $435.27 and $663.57. Thermo Fisher Scientific Inc. pays a dividend yielding 0.3%. View the live TMO chart, technical opinion, analyst ratings, fundamentals and latest news below.
Thermo Fisher Scientific Inc. (TMO) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $243.49B |
| P/E ratio (TTM) | 35.44 |
| EPS (TTM) | $18.58 |
| Dividend yield | 0.3% |
| 52-week high | $663.57 |
| 52-week low | $435.27 |
| Beta | 0.85 |
| Avg. volume | 2.10M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Frequently asked questions about Thermo Fisher Scientific Inc. (TMO)
How much does one share of Thermo Fisher Scientific Inc. cost?
As of the latest update, one share of Thermo Fisher Scientific Inc. (TMO) trades at $100 (+0.00% today).
What is Thermo Fisher Scientific Inc.'s market cap?
Thermo Fisher Scientific Inc. has a market capitalization of approximately $243.49B.
What is Thermo Fisher Scientific Inc.'s P/E ratio?
Thermo Fisher Scientific Inc. has a trailing price-to-earnings (P/E) ratio of 35.44.
What is Thermo Fisher Scientific Inc.'s earnings per share (EPS)?
Thermo Fisher Scientific Inc.'s trailing twelve-month EPS is $18.58.
Does Thermo Fisher Scientific Inc. pay a dividend?
Yes — Thermo Fisher Scientific Inc. pays a dividend with a yield of 0.3% ($1.88 per share annually).
What is Thermo Fisher Scientific Inc.'s 52-week trading range?
Over the past year, TMO has traded between $435.27 and $663.57.
What is the analyst price target for Thermo Fisher Scientific Inc.?
The mean analyst price target for Thermo Fisher Scientific Inc. is $649.96. This is informational only and not investment advice.
Latest Thermo Fisher Scientific Inc. (TMO) news
- Bioreactors Market Outlook 2026-2035 - Featuring Profiles of 3 Leading Companies: Sartorius, Thermo Fisher Scientific, and DanaherNews · Sep 23, 2026
- Gene Transfer Technologies Market Size, Share & Trends Analysis to 2036 Featuring Profiles of Thermo Fisher Scientific, Lonza Group, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Aldevron and MoreNews · Sep 23, 2026
- NICU Genetic Testing Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)News · Sep 22, 2026
- Europe Automated and Closed Cell Therapy Processing Systems Market Report (2026-2033) Featuring Profiles of Thermo Fisher Scientific, Cytiva, Sartorius, Miltenyi Biotec B.V. & Co., Lonza GroupNews · Sep 22, 2026
- Ultima Genomics Selected to Generate One Million-Sample, World-Leading Multi-omic Biomedical Dataset for AI/ML Precure, LLC InitiativeNews · Sep 22, 2026
- Capitalize on Drug Discovery Informatics: Benchmark Schrödinger, Certara, Dotmatics, Thermo Fisher and BIOVIA to Accelerate R&D ROI and Secure Market AdvantageNews · Sep 22, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live TMO dashboard…